Blood treatment could slash transfusion infection risk
NCT ID NCT03737669
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 18 times
Summary
This study tested whether treating donated blood with a special technology (Mirasol) can prevent infections like malaria, HIV, and hepatitis from being passed to patients during a transfusion. About 2000 people who needed a blood transfusion took part. The goal was to see if the treated blood led to fewer new infections compared to standard blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSFUSION-TRANSMITTED INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mulago Hospital Complex
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.